Terms: = Head and neck cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
112 results:
1. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
2. Mutation detection in saliva from oral cancer patients.
Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the regulatory interactions between mutated genes and homeobox genes in the head and neck cancer progression.
Padam KSR; Chakrabarty S; Hunter KD; Radhakrishnan R
Arch Oral Biol; 2024 Mar; 159():105872. PubMed ID: 38147801
[TBL] [Abstract] [Full Text] [Related]
4. Predictive capacity of fat1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.
León X; Llansana A; Pérez-Ugarte L; García J; Valero C; Quer M; Camacho M
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):359-364. PubMed ID: 37931687
[TBL] [Abstract] [Full Text] [Related]
5. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract] [Full Text] [Related]
6. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
Hunt PJ; Amit M; Kabotyanski KE; Aashiq M; Hanna EY; Kupferman ME; Su SY; Gidley PW; Nader ME; DeMonte F; Raza SM
Neurosurg Rev; 2023 Jun; 46(1):157. PubMed ID: 37386212
[TBL] [Abstract] [Full Text] [Related]
8. Genome sequencing reveals molecular subgroups in oral epithelial dysplasia.
Márquez A; Mujica I; Jordan N; Baez P; Tarquinio S; Nunes J; Adorno D; Martínez B; Morales-Pison S; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e063. PubMed ID: 37341234
[TBL] [Abstract] [Full Text] [Related]
9. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
Ju G; Yao Z; Zhao Y; Zhao X; Liu F
Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
[TBL] [Abstract] [Full Text] [Related]
10. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
Ko KP; Huang Y; Zhang S; Zou G; Kim B; Zhang J; Jun S; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Park JI
Gastroenterology; 2023 Sep; 165(3):613-628.e20. PubMed ID: 37257519
[TBL] [Abstract] [Full Text] [Related]
11. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract] [Full Text] [Related]
12. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
13. miR-183-5p overexpression orchestrates collective invasion in salivary adenoid cystic carcinoma through the fat1/YAP1 signaling pathway.
Chen BJ; Jiang J; Li T; Jiang HJ; Liang XH; Tang YL
Biochem Biophys Res Commun; 2023 May; 655():127-137. PubMed ID: 36934588
[TBL] [Abstract] [Full Text] [Related]
14. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
15. Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.
Dogan S; Xu B; Rana S; Chen H; Ghossein RA; Berger MF; Ho AL; Katabi N
Mod Pathol; 2023 Jul; 36(7):100150. PubMed ID: 36841437
[TBL] [Abstract] [Full Text] [Related]
16. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
17. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract] [Full Text] [Related]
18. Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma.
Ahn D; Kwak JH; Lee GJ; Sohn JH; Lee JE
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e239-e247. PubMed ID: 36178306
[TBL] [Abstract] [Full Text] [Related]
19. Oral cancer prediction by noninvasive genetic screening.
Poell JB; Wils LJ; Brink A; Dietrich R; Krieg C; Velleuer E; Evren I; Brouns ER; de Visscher JG; Bloemena E; Ylstra B; Brakenhoff RH
Int J Cancer; 2023 Jan; 152(2):227-238. PubMed ID: 36069231
[TBL] [Abstract] [Full Text] [Related]
20. Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.
Mai Z; Yuan J; Yang H; Fang S; Xie X; Wang X; Xie J; Wen J; Fu J
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993362
[TBL] [Abstract] [Full Text] [Related]
[Next]
